Development of a targeted drug delivery system for the treatment of hepatitis C virus infection
Background: Hepatitis C virus infection affects more than 170 million people worldwide and is frequently associated with chronic liver disease and hepatocellular carcinoma. No protective vaccine is yet available and the current standard of care, consisting of pegylated interferon alpha and ribavirin...
| Main Author: | |
|---|---|
| Format: | Thesis (University of Nottingham only) |
| Language: | English |
| Published: |
2012
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/14295/ |